7th Edition of Cardiology World Conference
October 08-10, 2026 | Tokyo, Japan
Cerebral Blood Flow and Metabolism
Cerebral Blood Flow : CBF is explained as the blood volume that flows per unit mass per unit time in brain tissue and is typically indicates in units of ml blood. Direct methods for calculating CBF in human subjects include single-photon emission computed tomography (SPECT), positron emission tomography (PET), MRI with contrast agents, and arterial spin labeling (ASL) MRI.
CBF is controlled by four major mechanisms:
- Metabolic control (or 'metabolic autoregulation')
- Pressure autoregulation.
- Chemical control (by arterial pCO2 and pO2)
- Neural control.
Metabolism: Metabolism is used to express all chemical reactions included in continuing the living state of the cells and the organism. Metabolism can be efficiently divided into two categories: Catabolism and Anabolism. Catabolism refers to the breakdown of molecules to obtain energy and Anabolism refers to the synthesis of all compounds needed by the cells.
Arthur J Siegel
Massachusetts General Hospital, United States
Sergey Suchkov
N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Narendra Kumar
HeartbeatsZ Academy, United Kingdom
Arthur J Siegel
Massachusetts General Hospital, United States
Yong Xiao Wang
Albany Medical Center, United States
Narendra Kumar
HeartbeatsZ Academy, United Kingdom
Sergey Suchkov
N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian FederationSubmit your abstract Today
Title : New recommendations for the prevention of sudden cardiac death in athletes and recreational sports
Sekib Sokolovic, ASA Hospital Sarajevo, Bosnia and Herzegowina
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation
Title : An adult case of polysplenia syndrome associated with sinus node dysfunction
Apoorva Tripathi, Oxford University Hospitals, United Kingdom
Title : Personalized and precision medicine (PPM) as a unique healthcare model through biodesign-driven translational applications and cardiology-related healthcare marketing to secure the human healthcare and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : A unique cell-driven phenomenon in the heart and the promising future of the innovative translational tools to manage cardiac self-renewal and regeneration
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Young hearts at risk: Hidden cardiovascular damage and the role of social determinants of health among youth with type 1 diabetes in Kenya
Phoebe Wamalwa, Ministry of Health, Kenya